TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 4.626
EU - Europa 3.009
AS - Asia 2.128
SA - Sud America 145
AF - Africa 29
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.951
Nazione #
US - Stati Uniti d'America 4.563
SG - Singapore 936
RU - Federazione Russa 769
HK - Hong Kong 671
IT - Italia 572
IE - Irlanda 487
DE - Germania 405
SE - Svezia 344
CN - Cina 251
BR - Brasile 123
ID - Indonesia 95
GB - Regno Unito 90
UA - Ucraina 63
CA - Canada 52
NL - Olanda 49
IN - India 47
AT - Austria 36
FI - Finlandia 33
VN - Vietnam 30
DK - Danimarca 28
BE - Belgio 23
FR - Francia 23
ES - Italia 15
TR - Turchia 15
CZ - Repubblica Ceca 14
JP - Giappone 14
AR - Argentina 10
KR - Corea 9
CH - Svizzera 8
PH - Filippine 8
AU - Australia 7
MA - Marocco 7
MX - Messico 7
PL - Polonia 7
SA - Arabia Saudita 7
TH - Thailandia 7
ZA - Sudafrica 7
EE - Estonia 6
IR - Iran 6
PK - Pakistan 6
BG - Bulgaria 5
GR - Grecia 5
TN - Tunisia 5
TW - Taiwan 5
HR - Croazia 4
IQ - Iraq 4
LT - Lituania 4
MY - Malesia 4
NO - Norvegia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CO - Colombia 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
PE - Perù 3
DO - Repubblica Dominicana 2
EC - Ecuador 2
ER - Eritrea 2
IL - Israele 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.951
Città #
Ann Arbor 669
Hong Kong 665
Singapore 585
Dublin 474
Chandler 403
Fairfield 387
Ashburn 296
Frankfurt am Main 259
New York 238
Princeton 223
Houston 179
Woodbridge 175
Wilmington 168
Santa Clara 167
Seattle 156
Cambridge 119
Lawrence 107
Milan 102
Altamura 99
Jakarta 93
Nuremberg 50
Shanghai 46
San Diego 44
Moscow 42
Toronto 41
Beijing 37
Jacksonville 37
Los Angeles 34
Rome 32
London 25
Andover 24
Brussels 22
Helsinki 20
Nanjing 20
Dearborn 19
Boardman 18
Chicago 18
Bergamo 14
Guangzhou 14
São Paulo 14
Vienna 14
Council Bluffs 13
Falls Church 13
Washington 11
Brno 10
Fuzhou 10
Pune 10
Hangzhou 9
Lappeenranta 9
Shenzhen 9
Dong Ket 8
Florence 8
Munich 8
Belo Horizonte 7
Brescia 7
Madrid 7
Norwalk 7
Redmond 7
Tokyo 7
Amsterdam 6
Bari 6
Cascina 6
Changsha 6
Chengdu 6
Groningen 6
Kilburn 6
Rio de Janeiro 6
San Mateo 6
Tallinn 6
Villafranca Padovana 6
Bologna 5
Düsseldorf 5
Hyderabad 5
Mumbai 5
Naples 5
Palermo 5
Portsmouth 5
Riyadh 5
Silver Spring 5
Stockholm 5
Wuhan 5
Zhengzhou 5
Belvedere Spinello 4
Brasília 4
Bratislava 4
Canegrate 4
Chennai 4
Deyang 4
Fremont 4
Genoa 4
Hebei 4
Islington 4
Lachine 4
Lauterbourg 4
Mexico City 4
Montecchio Maggiore 4
Oujda 4
Perugia 4
Poznan 4
Turin 4
Totale 6.507
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 287
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 259
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 192
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 183
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 165
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 159
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 154
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 140
Continuous subcutaneous insulin infusion in Italy: Third national survey 132
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 130
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 129
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 127
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 126
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 123
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 121
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 121
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 117
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 117
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 116
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 106
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 103
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 102
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 100
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 100
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 98
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 98
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 96
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 96
The Hyperfiltering Kidney in Diabetes 93
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 92
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 91
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 91
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 90
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 85
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 85
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 85
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 84
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 83
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 83
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 82
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 80
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 80
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 79
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 76
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 75
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 75
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 72
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 71
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 71
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 70
Lipids and renal disease 69
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 69
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 69
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 68
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 68
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 66
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 66
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 65
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study 64
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 63
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 63
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 63
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 63
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 63
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 62
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 61
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 61
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 61
In situ Protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 60
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 59
Treatment of diabetes in patients with kidney disease 59
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 59
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 59
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 58
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 58
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 58
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 57
Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 57
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 57
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial 57
Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 57
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus 56
Comparison of the night-time effectiveness in achieving glycemic targets in adults with type 1 diabetes of three advanced hybryd closed-loop systems 56
Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy 56
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 56
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 56
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 55
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 55
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 53
Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 53
The effect of Mindfulness therapy in acromegaly, a pilot study 52
Preventing microalbuminuria in type 2 diabetes 52
The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 52
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 52
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 52
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 52
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 52
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial 51
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes 50
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme 50
Totale 8.520
Categoria #
all - tutte 60.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 0 0 0 0 0 0 35 20
2020/20211.525 176 174 157 119 74 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/20253.564 249 483 171 193 449 222 198 136 745 717 1 0
Totale 10.582